Leptin: Structure, function and biology

被引:248
作者
Zhang, FM [1 ]
Chen, YY
Heiman, M
Dimarchi, R
机构
[1] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA
[2] Eli Lilly & Co, Div Endocrine Res, Lilly Corp Ctr, Indianapolis, IN 46285 USA
来源
VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 71 | 2005年 / 71卷
关键词
D O I
10.1016/S0083-6729(05)71012-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leptin is an adipocyte-derived hormone that acts as a major regulator for food intake and energy homeostasis. Leptin deficiency or resistance can result in profound obesity, diabetes, and infertility in humans. Since its discovery, our understanding of leptin's biological functions has expanded from antiobesity to broad effects on reproduction, hematopoiesis, angiogenesis, blood pressure, bone mass, lymphoid organ homeostasis, and T lymphocyte systems. Leptin orchestrates complex biological effects through its receptors, expressed both centrally and peripherally. Leptin receptor belongs to the class I cytokine receptor superfamily. At least five isoforms of leptin receptor exist, primarily because of alternate splicing. The longest form is capable of full signal transduction. The short forms may serve as leptin binding proteins and play a role in leptin transporting across the blood-brain barrier. In this review, we present the crystal structure of leptin and the structural comparison with other four-helical cytokines, discuss the leptin-receptor binding models based on other cytokine-receptor complex structures, and summarize the most recent progress on leptin signal transduction pathways - especially its link to peripheral lipid metabolism through AMP-activated protein kinase and hepatic stearoyl-CoA desaturase-1 pathways. Furthermore, we propose the structure based design of leptin analogs with increased stability, improved potency, enhanced blood-brain barrier transport, and extended time action for future therapeutic application. (c) 2005 Elsevier Inc.
引用
收藏
页码:345 / +
页数:30
相关论文
共 124 条
[11]  
BJORKHOLM JE, 1998, INTEL TECHNOL J Q, V3, P1
[12]   Hexameric structure and assembly of the interleukin-6/IL-6 α-receptor/gp130 complex [J].
Boulanger, MJ ;
Chow, DC ;
Brevnova, EE ;
Garcia, KC .
SCIENCE, 2003, 300 (5628) :2101-2104
[13]   The future of leptin and leptin analogues in the treatment of obesity [J].
Bryson, JM .
DIABETES OBESITY & METABOLISM, 2000, 2 (02) :83-89
[14]   IRS-2 pathways integrate female reproduction and energy homeostasis [J].
Burks, DJ ;
de Mora, JF ;
Schubert, M ;
Withers, DJ ;
Myers, MG ;
Towery, HH ;
Altamuro, SL ;
Flint, CL ;
White, MF .
NATURE, 2000, 407 (6802) :377-382
[15]  
CAMMISOTTO PG, 2004, AM J PHYSIOL-REG I, V26, P26
[16]   RECOMBINANT MOUSE OB PROTEIN - EVIDENCE FOR A PERIPHERAL SIGNAL LINKING ADIPOSITY AND CENTRAL NEURAL NETWORKS [J].
CAMPFIELD, LA ;
SMITH, FJ ;
GUISEZ, Y ;
DEVOS, R ;
BURN, P .
SCIENCE, 1995, 269 (5223) :546-549
[17]  
Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490
[18]   Chronic leptin administration promotes lipid utilization until fat mass is greatly reduced and preserves lean mass of normal female rats [J].
Chen, YY ;
Heiman, ML .
REGULATORY PEPTIDES, 2000, 92 (1-3) :113-119
[19]   Indication for linkage of the human OB gene region with extreme obesity [J].
Clement, K ;
Garner, C ;
Hager, J ;
Philippi, A ;
LeDuc, C ;
Carey, A ;
Harris, TJR ;
Jury, C ;
Cardon, LR ;
Basdevant, A ;
Demenais, F ;
GuyGrand, B ;
North, M ;
Froguel, P .
DIABETES, 1996, 45 (05) :687-690
[20]   A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction [J].
Clément, K ;
Vaisse, C ;
Lahlou, N ;
Cabrol, S ;
Pelloux, V ;
Cassuto, D ;
Gourmelen, M ;
Dina, C ;
Chambaz, J ;
Lacorte, JM ;
Basdevant, A ;
Bougneres, P ;
Lebouc, Y ;
Froguel, P ;
Guy-Grand, B .
NATURE, 1998, 392 (6674) :398-401